Role ofFDFT1polymorphism for fibrosis progression in patients with chronic hepatitis C

Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin

(2012) L. Valenti et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease

(2012) Hae-Ki Min et al.   Cell Metabolism

Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C

(2012) Albert Friedrich Stättermayer et al.   JOURNAL OF HEPATOLOGY

Polymorphism in the Farnesyl Diphosphate Farnesyl Transferase 1 Gene and Nonalcoholic Fatty Liver Disease Severity

(2011) Stefano Ballestri et al.   GASTROENTEROLOGY

A High-Cholesterol Diet Exacerbates Liver Fibrosis in Mice via Accumulation of Free Cholesterol in Hepatic Stellate Cells

(2011) Toshiaki Teratani et al.   GASTROENTEROLOGY

Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C

(2011) Eric Trépo et al.   HEPATOLOGY

Distinct, alcohol-modulated effects of PNPLA3 genotype on progression of chronic hepatitis C

(2011) Tobias Müller et al.   JOURNAL OF HEPATOLOGY

Modulation of the effect of PNPLA3 I148M mutation on steatosis and liver damage by alcohol intake in patients with chronic hepatitis C

(2011) Luca Valenti et al.   JOURNAL OF HEPATOLOGY

Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C

(2011) Hans L. Tillmann et al.   JOURNAL OF HEPATOLOGY

Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C

(2011) Arun J. Sanyal   LIVER INTERNATIONAL

Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Naïve Patients With Chronic Hepatitis C

(2010) Albert Friedrich Stättermayer et al.   Clinical Gastroenterology and Hepatology

Genome-Wide Association Study Identifies Variants Associated With Histologic Features of Nonalcoholic Fatty Liver Disease

(2010) Naga Chalasani et al.   GASTROENTEROLOGY

Liver X Receptor Signaling Is a Determinant of Stellate Cell Activation and Susceptibility to Fibrotic Liver Disease

(2010) Simon W. Beaven et al.   GASTROENTEROLOGY

Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C

(2010) Luca Valenti et al.   HEPATOLOGY

Peginterferon Alfa-2a/Ribavirin for 48 or 72 Weeks in Hepatitis C Genotypes 1 and 4 Patients With Slow Virologic Response

(2009) Peter Ferenci et al.   GASTROENTEROLOGY

Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH

(2009) Francisco Caballero et al.   JOURNAL OF HEPATOLOGY

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response

(2008) Peter Ferenci et al.   GASTROENTEROLOGY